Currently, there is a trend of increasing incidence in pulmonary non-tuberculous
mycobacterial infections (PNTM) together with a decrease in tuberculosis (TB) incidence …

A close association with its vertebrate and tick hosts allows Borrelia burgdorferi, the
bacterium responsible for Lyme disease, to eliminate many metabolic pathways and instead …

Tuberculosis remains one of the leading public health problems in the world. The
mechanisms that lead to the activation of the immune response against Mycobacterium …

Tuberculosis is a challenging disease due to the intracellular residence of its pathogen,
Mycobacterium tuberculosis, and modulation of the host bactericidal responses. Lipids from …

Anti-lipid IgG antibodies are produced in some mycobacterial infections and in certain
autoimmune diseases [such as anti-phospholipid syndrome, systemic lupus erythematosus …

Tuberculosis (TB) is a chronic disease caused by Mycobacterium tuberculosis (Mtb), which
shows a long treatment cycle often leads to drug resistance, making treatment more difficult …

Methods: M. smegmatis expressing three T cell epitopes from M. tuberculosis Ag85B (P21,
P26, and P53) was constructed (rMs064). rMs064 was used to immunize BALB/C mice for …

A more effective vaccine against tuberculosis (TB) is urgently needed. Based on its high
genetic homology with Mycobacterium tuberculosis (Mtb), the nonpathogenic mycobacteria …

Tuberculosis (TB) remains an important cause of mortality and morbidity. The TB vaccine,
BCG, is not fully protective against the adult form of the disease and is unable to prevent its …

Anti-lipid antibodies are present in some infectious and autoimmune diseases, such as
Systemic Lupus Erythematosus (SLE). Particularly, anti-non-bilayer phospholipid …